Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C.

Osteoarthritis Cartilage. 2009 Mar;17(3):384-9. doi: 10.1016/j.joca.2008.07.009.

2.

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.

Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY; Group for the Respect of Excellence and Ethics in Science..

Osteoarthritis Cartilage. 2004 Apr;12(4):263-8. Review.

3.

Radiologic markers of osteoarthritis progression.

Hunter DJ, Le Graverand MP, Eckstein F.

Curr Opin Rheumatol. 2009 Mar;21(2):110-7. doi: 10.1097/BOR.0b013e3283235add. Review.

PMID:
19339920
5.

The evolving role of biomarkers for osteoarthritis.

Ishijima M, Kaneko H, Kaneko K.

Ther Adv Musculoskelet Dis. 2014 Aug;6(4):144-53. doi: 10.1177/1759720X14541175. Review.

Supplemental Content

Support Center